Ion Petre

MN
h-index22
5papers
1,994citations
Novelty43%
AI Score22

5 Papers

7.9LOJul 14
A Unified Framework for Reaction Systems Based on Interval Structures

Paolo Bottoni, Anna Labella, Ion Petre

Reaction systems have evolved into a rich family of computational models differing in their treatment of multiplicities, resource management, concurrency, and state evolution. We introduce a unified semantic framework based on interval structures and interval-based transformation systems. The framework decomposes operational semantics into independent resource, production, update, and execution strategies, providing a common basis for describing, comparing, and constructing reaction-system variants. We show that classical reaction systems, restricted reaction systems, multiset reaction systems, reaction systems with concentration, and resource-preserving multiset reaction systems are all recovered as instantiations of the framework. Quantitative reaction systems are accommodated through an additional preprocessing stage. We further demonstrate that the framework naturally extends beyond reaction systems to other computational models, including Petri nets. The proposed framework provides a common semantic foundation for existing models and a flexible basis for developing and analysing new computational formalisms.

1.2DMJul 6, 2024
Strong regulatory graphs

Patric Gustafsson, Ion Petre

Logical modeling is a powerful tool in biology, offering a system-level understanding of the complex interactions that govern biological processes. A gap that hinders the scalability of logical models is the need to specify the update function of every vertex in the network depending on the status of its predecessors. To address this, we introduce in this paper the concept of strong regulation, where a vertex is only updated to active/inactive if all its predecessors agree in their influences; otherwise, it is set to ambiguous. We explore the interplay between active, inactive, and ambiguous influences in a network. We discuss the existence of phenotype attractors in such networks, where the status of some of the variables is fixed to active/inactive, while the others can have an arbitrary status, including ambiguous.

9.9LGJun 12
Machine Learning for Biomedical Raman Spectroscopy: From Spectral Acquisition to Clinical Translation

Bogdan Oancea, Ana Maria Seciu-Grama, Nicoleta Siminea et al.

Raman spectroscopy provides label-free, chemically specific characterization of biological systems and has become an important tool for cancer diagnosis, molecular subtyping, microbiological identification, and intraoperative decision support. Biomedical Raman spectra are, however, high-dimensional, noisy, and affected by fluorescence background, acquisition variability, and biological heterogeneity, making robust computational analysis essential. This review examines the role of machine learning across the biomedical Raman spectroscopy pipeline, from preprocessing and signal correction to unsupervised structure discovery, supervised diagnosis and molecular stratification, representation and transfer learning, explainability, biomarker discovery, and multimodal integration with imaging, pathology, and molecular profiling. Emphasis is placed on the use of machine learning not only for diagnostic classification, but also for biologically interpretable and clinically actionable analysis. We also discuss the main barriers to clinical translation, including limited dataset sizes, inter-instrument variability, inconsistent preprocessing, insufficient external validation, reproducibility concerns, and limited sharing of software, data, and metadata. We argue that progress will require methodological advances together with standardization, robust validation, explainability, and deployment-ready analytical frameworks. By integrating methodological, biomedical, and translational perspectives, this review outlines key directions for developing reliable and clinically deployable Raman-AI systems.

1.2MNMay 20, 2021
Towards Scalable Modeling of Biology in Event-B

Usman Sanwal, Thai Son Hoang, Luigia Petre et al.

Biology offers many examples of large-scale, complex, concurrent systems: many processes take place in parallel, compete on resources and influence each other's behavior. The scalable modeling of biological systems continues to be a very active field of research. In this paper we introduce a new approach based on Event-B, a state-based formal method with refinement as its central ingredient, allowing us to check for model consistency step-by-step in an automated way. Our approach based on functions leads to an elegant and concise modeling method. We demonstrate this approach by constructing what is, to our knowledge, the largest ever built Event-B model, describing the ErbB signaling pathway, a key evolutionary pathway with a significant role in development and in many types of cancer. The Event-B model for the ErbB pathway describes 1320 molecular reactions through 242 events.

1.2MNJul 9, 2020
Identifying efficient controls of complex interaction networks using genetic algorithms

Victor-Bogdan Popescu, Krishna Kanhaiya, Iulian Năstac et al.

Control theory has seen recently impactful applications in network science, especially in connections with applications in network medicine. A key topic of research is that of finding minimal external interventions that offer control over the dynamics of a given network, a problem known as network controllability. We propose in this article a new solution for this problem based on genetic algorithms. We tailor our solution for applications in computational drug repurposing, seeking to maximise its use of FDA-approved drug targets in a given disease-specific protein-protein interaction network. We show how our algorithm identifies a number of potentially efficient drugs for breast, ovarian, and pancreatic cancer. We demonstrate our algorithm on several benchmark networks from cancer medicine, social networks, electronic circuits, and several random networks with their edges distributed according to the Erdős-Rényi, the small-world, and the scale-free properties. Overall, we show that our new algorithm is more efficient in identifying relevant drug targets in a disease network, advancing the computational solutions needed for new therapeutic and drug repurposing approaches.